Gemcitabine

British Journal of Hospital Medicine

Volumn 57, Issue 8, 1997, Pages 405-409

  Prendiville, J ^a   O'Brien, M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DNA; DRUG DERIVATIVE; GEMCITABINE; NUCLEIC ACID SYNTHESIS INHIBITOR;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; DRUG COST; DRUG EFFECT; ECONOMICS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; OVARY TUMOR; PANCREAS TUMOR;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DNA; DRUG COSTS; FEMALE; HUMANS; LUNG NEOPLASMS; NUCLEIC ACID SYNTHESIS INHIBITORS; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS;

EID: 0031574730     PISSN: 00071064     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Abratt RP, Bezwpda WR, Goedhals L et al (1995) A phase 2 study of gemcitabine with cisplatin in patients with non-small cell lung cancer. Proc Am Soc Clin Oncol 14: 375 (abstract 1159)
2. Abbruzzese JL (1996) Phase I studies with the novel nucleoside analog gemcitabine. Semin Oncol 23(5) (Suppl 10):
3. Anderson H, Lund B, Bach F et al (1994) Single agent activity of weekly gemcitabine in advanced non-small cell lung cancer: a phase II study./ Clin Oncol 12: 1821-6
4. CarmichaelJ, Allerheiligen S, Walling J (1996) A phase I study of gemcitabine and carboplatin in non-small cell lung cancer. Semin Oncol 23(5) (Suppl 10): 55-9
5. CarmichaelJ, Walling J (1996) Phase II activity of gemcitabine in advanced breast cancer. Semin Oncol 23(5) (Suppl 10): 77-81
6. Copley-Merriman C, Martin C, Johnson N et al (1996) Economic value of gemcitabine in non-small cell lung cancer. Semm Oncol 23(5) (Suppl 10): 90-8
7. Crino L, Scagliotti G, Marangolo M et al (1995) Cisplatin-gemcitabine m non-small cell lung cancer (NSCLC). A phase II study. Proc Am Soc Clin Oncol 14: 352 (abstract 1064)
8. Fossella FV, Lippman SM, Tarassoff P et al (1995) Phase I/I I study of gemcitabine. An active agent for advanced nonsmall cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 14:371 (abstract 1144)
9. Evans WK (1996) An estimate of the cost effectiveness of gemcitabine in stage IV non-small cell lung cancer. Semin Oncol 23(5) (Suppl 10): 82-9
10. Guchelaar HJ, Richel DJ, van Knapen A (1996) Clinical, toxicological and pharmacological aspects of gemcitabine. Cancer Treat Rev 22: 15-31
11. Hardy JR, Noble T, Smith IE (1989) Symptom relief with moderate dose chemotherapy (mitomycin C, vinblastine and cisplatin) in advanced non small cell lung cancer. Br J Cancer 60: 764-6
12. Koch P, Johnson N, van Schaik J et al (1995) Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer. Anticancer Drugs 6 (suppl 6): 49-54
13. Le Chevalier T (1996) Single agent activity of gemcitabine in advanced non-small cell lung cancer. Semin Oncol 23(5) (Suppl 10): 36-42
14. Moore M (1996) Activity of gemcitabine in patients with advanced pancreatic carcinoma. Cancer (Suppl) 78: 633-8
15. Moore MJ, Andersen J, Burris H et al (1995) A randomised trial of gemcitabme vs 5FU as first line therapy in advanced pancreatic cancer (abstract). Proc Am Soc Clin Oncol 14: 198
16. Peters GJ, Ruiz van Haperen VWT, Bergman AM et al (1996) Preclinical combination therapy with gemcitabine and mechanisms of resistance. Semin Oncol 23(5) (Suppl 10): 16-24
17. Sandler AB, Ansari R, McClean J et al (1995) Gemcitabine plus cisplatin m non-small cell lung cancer: a phase II study. Proc Am Soc Clin Oncol 14: 357 (abstract 1079)
18. Shepherd FA (1995) Phase II trials of single-agent activity of gemcitabine in patients with advanced non-small cell lung cancer: an overview. Anticancer Drugs 6 (suppl 6): 19-25
19. Shepherd FA, Burkes RL, Cormier Y et al (1996) Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer. Semin Oncol 23(5) (Suppl 10): 48-54
20. Steward PS, Dunlop DJ, Dabouis G, Lacroix H, Talbot D (1996) Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results. Semin Oncol 25(5) (Suppl 10): 43-7
21. Thatcher N, Anderson H, Betticher DC, Ranson M (1995) Symptomatic benefit from gemcitabine and other chemotherapy in advanced non small cell lung cancer: changes in performance status and tumour-related symptoms. Anticancer Drugs 6 (suppl 6): 39-48